Fast Market Research

Market Report, "AEterna Zentaris Inc. - Product Pipeline Review - 2013", Published

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 06/21/2013 -- Global Market Direct's pharmaceuticals report, "AEterna Zentaris Inc. - Product Pipeline Review - 2013" provides data on the AEterna Zentaris Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, AEterna Zentaris Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from AEterna Zentaris Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- AEterna Zentaris Inc. - Brief AEterna Zentaris Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AEterna Zentaris Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of AEterna Zentaris Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the AEterna Zentaris Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate AEterna Zentaris Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of AEterna Zentaris Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the AEterna Zentaris Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with AEterna Zentaris Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of AEterna Zentaris Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- AEterna Zentaris Inc. - Product Pipeline Review - 2012
- AEterna Zentaris Inc. (AEZ) - Financial and Strategic SWOT Analysis Review
- Cachexia - Pipeline Review, H1 2013
- Muscle Wasting Disorders - Pipeline Review, H1 2013
- Cancer Cachexia - Pipeline Review, H1 2013
- Malignant Mesothelioma - Pipeline Review, H1 2013
- Alcohol Addiction - Pipeline Review, H1 2013
- Malignant Pleural Mesothelioma - Pipeline Review, H1 2013
- Growth Hormone Deficiency - Pipeline Review, H1 2013
- Paladin Labs Inc. - Product Pipeline Review - 2013